Roche Holding AG
Bear Case (25th pct.)
-25.5% vs price
Base Case (Median)
32.1% vs price
Bull Case (75th pct.)
42.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $580.64 | 32.1% | High (40%) |
| PE Comparable | $601.09 | 36.8% | Medium (25%) |
| Growth Trajectory DCF | $654.46 | 48.9% | Medium (20%) |
| Graham Number | $160.68 | -63.4% | Medium (40%) |
| EV/EBITDA | $284.77 | -35.2% | Medium (20%) |
| EV/FCF | $729.90 | 66.1% | Medium (20%) |
| Earnings Power Value | $369.87 | -15.8% | Medium (50%) |
Based on 7 out of 8 methods, RHHVF appears fairly valued at the current price of $439.41. The base case fair value of $580.64 implies 32.1% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.